David H. Persing, Executive VP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 285 shares at $32.85 ($9K) on 2011-06-15, disclosed to the SEC on 2011-06-16.
Scheduled sale ($9k) by Executive VP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |